Logo image of SMCRT.OL

SMARTCRAFT ASA (SMCRT.OL) Stock Fundamental Analysis

OSL:SMCRT - Euronext Oslo - NO0011008971 - Common Stock - Currency: NOK

26.4  -0.4 (-1.49%)

Fundamental Rating

6

Taking everything into account, SMCRT scores 6 out of 10 in our fundamental rating. SMCRT was compared to 100 industry peers in the Software industry. SMCRT scores excellent on profitability, but there are some minor concerns on its financial health. SMCRT is showing excellent growth while it is valued at reasonable prices. Keep and eye on this one! These ratings would make SMCRT suitable for growth investing!


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

In the past year SMCRT was profitable.
SMCRT had a positive operating cash flow in the past year.
In the past 5 years SMCRT has always been profitable.
SMCRT had a positive operating cash flow in each of the past 5 years.
SMCRT.OL Yearly Net Income VS EBIT VS OCF VS FCFSMCRT.OL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

1.2 Ratios

With a decent Return On Assets value of 7.53%, SMCRT is doing good in the industry, outperforming 78.00% of the companies in the same industry.
With a decent Return On Equity value of 10.48%, SMCRT is doing good in the industry, outperforming 65.00% of the companies in the same industry.
With a decent Return On Invested Capital value of 9.69%, SMCRT is doing good in the industry, outperforming 77.00% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for SMCRT is in line with the industry average of 11.09%.
Industry RankSector Rank
ROA 7.53%
ROE 10.48%
ROIC 9.69%
ROA(3y)8.35%
ROA(5y)6.97%
ROE(3y)11.09%
ROE(5y)10.12%
ROIC(3y)11.14%
ROIC(5y)10.01%
SMCRT.OL Yearly ROA, ROE, ROICSMCRT.OL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 2 4 6 8 10

1.3 Margins

Looking at the Profit Margin, with a value of 18.01%, SMCRT belongs to the top of the industry, outperforming 83.00% of the companies in the same industry.
In the last couple of years the Profit Margin of SMCRT has grown nicely.
With an excellent Operating Margin value of 23.10%, SMCRT belongs to the best of the industry, outperforming 87.00% of the companies in the same industry.
SMCRT's Operating Margin has been stable in the last couple of years.
SMCRT has a better Gross Margin (91.34%) than 93.00% of its industry peers.
SMCRT's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 23.1%
PM (TTM) 18.01%
GM 91.34%
OM growth 3Y4.37%
OM growth 5Y0.76%
PM growth 3Y15.25%
PM growth 5Y2.97%
GM growth 3Y3.1%
GM growth 5Y0.76%
SMCRT.OL Yearly Profit, Operating, Gross MarginsSMCRT.OL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 20 40 60 80

6

2. Health

2.1 Basic Checks

SMCRT has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
Compared to 1 year ago, SMCRT has less shares outstanding
SMCRT has about the same amout of shares outstanding than it did 5 years ago.
The debt/assets ratio for SMCRT is higher compared to a year ago.
SMCRT.OL Yearly Shares OutstandingSMCRT.OL Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M
SMCRT.OL Yearly Total Debt VS Total AssetsSMCRT.OL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.2 Solvency

SMCRT has an Altman-Z score of 8.61. This indicates that SMCRT is financially healthy and has little risk of bankruptcy at the moment.
The Altman-Z score of SMCRT (8.61) is better than 82.00% of its industry peers.
The Debt to FCF ratio of SMCRT is 0.34, which is an excellent value as it means it would take SMCRT, only 0.34 years of fcf income to pay off all of its debts.
Looking at the Debt to FCF ratio, with a value of 0.34, SMCRT belongs to the top of the industry, outperforming 91.00% of the companies in the same industry.
SMCRT has a Debt/Equity ratio of 0.02. This is a healthy value indicating a solid balance between debt and equity.
With an excellent Debt to Equity ratio value of 0.02, SMCRT belongs to the best of the industry, outperforming 88.00% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.02
Debt/FCF 0.34
Altman-Z 8.61
ROIC/WACC1.06
WACC9.11%
SMCRT.OL Yearly LT Debt VS Equity VS FCFSMCRT.OL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

2.3 Liquidity

A Current Ratio of 0.82 indicates that SMCRT may have some problems paying its short term obligations.
SMCRT has a Current ratio of 0.82. This is in the lower half of the industry: SMCRT underperforms 74.00% of its industry peers.
SMCRT has a Quick Ratio of 0.82. This is a bad value and indicates that SMCRT is not financially healthy enough and could expect problems in meeting its short term obligations.
The Quick ratio of SMCRT (0.82) is worse than 72.00% of its industry peers.
Industry RankSector Rank
Current Ratio 0.82
Quick Ratio 0.82
SMCRT.OL Yearly Current Assets VS Current LiabilitesSMCRT.OL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

8

3. Growth

3.1 Past

The earnings per share for SMCRT have decreased strongly by -13.14% in the last year.
Measured over the past years, SMCRT shows a very strong growth in Earnings Per Share. The EPS has been growing by 30.82% on average per year.
Looking at the last year, SMCRT shows a very strong growth in Revenue. The Revenue has grown by 28.95%.
Measured over the past years, SMCRT shows a very strong growth in Revenue. The Revenue has been growing by 27.15% on average per year.
EPS 1Y (TTM)-13.14%
EPS 3Y38.9%
EPS 5Y30.82%
EPS Q2Q%-31.58%
Revenue 1Y (TTM)28.95%
Revenue growth 3Y23.56%
Revenue growth 5Y27.15%
Sales Q2Q%24.8%

3.2 Future

SMCRT is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 21.94% yearly.
The Revenue is expected to grow by 13.00% on average over the next years. This is quite good.
EPS Next Y16.16%
EPS Next 2Y20.77%
EPS Next 3Y21.94%
EPS Next 5YN/A
Revenue Next Year12.69%
Revenue Next 2Y12.23%
Revenue Next 3Y13%
Revenue Next 5YN/A

3.3 Evolution

The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
SMCRT.OL Yearly Revenue VS EstimatesSMCRT.OL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 200M 400M 600M
SMCRT.OL Yearly EPS VS EstimatesSMCRT.OL Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 0.2 0.4 0.6 0.8 1

4

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 43.28 indicates a quite expensive valuation of SMCRT.
Based on the Price/Earnings ratio, SMCRT is valued a bit cheaper than 67.00% of the companies in the same industry.
The average S&P500 Price/Earnings ratio is at 27.21. SMCRT is valued rather expensively when compared to this.
Based on the Price/Forward Earnings ratio of 27.09, the valuation of SMCRT can be described as expensive.
SMCRT's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. SMCRT is cheaper than 64.00% of the companies in the same industry.
SMCRT is valuated rather expensively when we compare the Price/Forward Earnings ratio to 21.70, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 43.28
Fwd PE 27.09
SMCRT.OL Price Earnings VS Forward Price EarningsSMCRT.OL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of SMCRT indicates a somewhat cheap valuation: SMCRT is cheaper than 63.00% of the companies listed in the same industry.
SMCRT's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. SMCRT is cheaper than 67.00% of the companies in the same industry.
Industry RankSector Rank
P/FCF 42.68
EV/EBITDA 21.3
SMCRT.OL Per share dataSMCRT.OL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2 3 4 5

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
SMCRT has a very decent profitability rating, which may justify a higher PE ratio.
A more expensive valuation may be justified as SMCRT's earnings are expected to grow with 21.94% in the coming years.
PEG (NY)2.68
PEG (5Y)1.4
EPS Next 2Y20.77%
EPS Next 3Y21.94%

0

5. Dividend

5.1 Amount

SMCRT does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

SMARTCRAFT ASA

OSL:SMCRT (7/1/2025, 4:11:39 PM)

26.4

-0.4 (-1.49%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)05-07 2025-05-07/bmo
Earnings (Next)N/A N/A
Inst Owners40.99%
Inst Owner ChangeN/A
Ins Owners1%
Ins Owner ChangeN/A
Market Cap4.53B
Analysts82.86
Price Target32.42 (22.8%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-20.93%
Min EPS beat(2)-22.72%
Max EPS beat(2)-19.14%
EPS beat(4)0
Avg EPS beat(4)-18.48%
Min EPS beat(4)-22.72%
Max EPS beat(4)-10.07%
EPS beat(8)1
Avg EPS beat(8)-5.84%
EPS beat(12)3
Avg EPS beat(12)-4.62%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-5.84%
Min Revenue beat(2)-6.15%
Max Revenue beat(2)-5.52%
Revenue beat(4)0
Avg Revenue beat(4)-4.65%
Min Revenue beat(4)-6.79%
Max Revenue beat(4)-0.13%
Revenue beat(8)0
Avg Revenue beat(8)-3.67%
Revenue beat(12)1
Avg Revenue beat(12)-3.83%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-0.52%
PT rev (3m)-2.56%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-12.73%
EPS NY rev (1m)0%
EPS NY rev (3m)-3.42%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-2.71%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.84%
Valuation
Industry RankSector Rank
PE 43.28
Fwd PE 27.09
P/S 8.42
P/FCF 42.68
P/OCF 28.34
P/B 4.9
P/tB N/A
EV/EBITDA 21.3
EPS(TTM)0.61
EY2.31%
EPS(NY)0.97
Fwd EY3.69%
FCF(TTM)0.62
FCFY2.34%
OCF(TTM)0.93
OCFY3.53%
SpS3.14
BVpS5.39
TBVpS-0.59
PEG (NY)2.68
PEG (5Y)1.4
Profitability
Industry RankSector Rank
ROA 7.53%
ROE 10.48%
ROCE 12.24%
ROIC 9.69%
ROICexc 11.4%
ROICexgc N/A
OM 23.1%
PM (TTM) 18.01%
GM 91.34%
FCFM 19.72%
ROA(3y)8.35%
ROA(5y)6.97%
ROE(3y)11.09%
ROE(5y)10.12%
ROIC(3y)11.14%
ROIC(5y)10.01%
ROICexc(3y)13.91%
ROICexc(5y)12.37%
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)14.07%
ROCE(5y)12.65%
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3Y12.62%
ROICexc growth 5Y9.01%
OM growth 3Y4.37%
OM growth 5Y0.76%
PM growth 3Y15.25%
PM growth 5Y2.97%
GM growth 3Y3.1%
GM growth 5Y0.76%
F-Score6
Asset Turnover0.42
Health
Industry RankSector Rank
Debt/Equity 0.02
Debt/FCF 0.34
Debt/EBITDA 0.1
Cap/Depr 62.43%
Cap/Sales 9.98%
Interest Coverage 39.01
Cash Conversion 75.98%
Profit Quality 109.5%
Current Ratio 0.82
Quick Ratio 0.82
Altman-Z 8.61
F-Score6
WACC9.11%
ROIC/WACC1.06
Cap/Depr(3y)89.02%
Cap/Depr(5y)87.97%
Cap/Sales(3y)9.14%
Cap/Sales(5y)8.43%
Profit Quality(3y)114.47%
Profit Quality(5y)158.42%
High Growth Momentum
Growth
EPS 1Y (TTM)-13.14%
EPS 3Y38.9%
EPS 5Y30.82%
EPS Q2Q%-31.58%
EPS Next Y16.16%
EPS Next 2Y20.77%
EPS Next 3Y21.94%
EPS Next 5YN/A
Revenue 1Y (TTM)28.95%
Revenue growth 3Y23.56%
Revenue growth 5Y27.15%
Sales Q2Q%24.8%
Revenue Next Year12.69%
Revenue Next 2Y12.23%
Revenue Next 3Y13%
Revenue Next 5YN/A
EBIT growth 1Y-6.86%
EBIT growth 3Y28.96%
EBIT growth 5Y28.12%
EBIT Next Year50.64%
EBIT Next 3Y29.8%
EBIT Next 5YN/A
FCF growth 1Y5.25%
FCF growth 3Y14.53%
FCF growth 5Y29.46%
OCF growth 1Y22.78%
OCF growth 3Y18.89%
OCF growth 5Y30.95%